Hemophagocytic Lymphohistiocytoses Clinical Trials

7 recruiting

Hemophagocytic Lymphohistiocytoses Trials at a Glance

7 actively recruiting trials for hemophagocytic lymphohistiocytoses are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 2 with 1 trial, with the heaviest enrollment activity in Birmingham, Cincinnati, and Irvine. Lead sponsors running hemophagocytic lymphohistiocytoses studies include Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Institut National de la Santé Et de la Recherche Médicale, France, and Children's Hospital Medical Center, Cincinnati.

Browse hemophagocytic lymphohistiocytoses trials by phase

Treatments under study

About Hemophagocytic Lymphohistiocytoses Clinical Trials

Looking for clinical trials for Hemophagocytic Lymphohistiocytoses? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hemophagocytic Lymphohistiocytoses trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hemophagocytic Lymphohistiocytoses clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Prospective Cohort for Adult Hemophagocytosis

Hemophagocytic Lymphohistiocytoses
Samsung Medical Center81 enrolled1 locationNCT03117010
Recruiting
Phase 2

Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)

Hemophagocytic Lymphohistiocytoses
Jerry Lee, MD, MSc, MPhil36 enrolled3 locationsNCT06160791
Recruiting

INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)

Hemophagocytic Lymphohistiocytoses
Children's Hospital Medical Center, Cincinnati200 enrolled1 locationNCT05277272
Recruiting

Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis

LymphomaHemophagocytic Lymphohistiocytoses
University of Alabama at Birmingham2,000 enrolled1 locationNCT05898477
Recruiting

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Autoimmune HepatitisSystemic Lupus ErythematosusHemophagocytic Lymphohistiocytoses+17 more
Institut National de la Santé Et de la Recherche Médicale, France500 enrolled1 locationNCT04902807
Recruiting

Prospective Validation of the OHI Index

Hematologic MalignancyHematologic NeoplasmsHLH+2 more
Meir Medical Center300 enrolled2 locationsNCT05882175
Recruiting

Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas

LymphomaHemophagocytic Lymphohistiocytoses
Fondazione Policlinico Universitario Agostino Gemelli IRCCS150 enrolled1 locationNCT06585124